# Antibiotics and Hydroxychloroquine in Crohn's

> **NCT01783106** · PHASE2 · COMPLETED · sponsor: **Royal Liverpool University Hospital** · enrollment: 59 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** Ciprofloxacin
- **DRUG:** Doxycycline
- **DRUG:** Hydroxychloroquine
- **DRUG:** Budesonide

## Key facts

- **NCT ID:** NCT01783106
- **Lead sponsor:** Royal Liverpool University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02-01
- **Primary completion:** 2019-04-18
- **Final completion:** 2019-09-30
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2019-10-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01783106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01783106, "Antibiotics and Hydroxychloroquine in Crohn's". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01783106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*